Company Search:
Advanced Search
Sponsored Links
Ascendis Pharma A/S - ADR Company Snapshot
Ascendis Pharma A/S operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ascendis Pharma A/S with three other companies in this sector in the United States: Precision BioSciences Inc (2018 sales of $10.88 million of which 88% was Therapeutics), Arvinas Inc ($14.32 million of which 100% was Biopharmaceutical), and Vir Biotechnology Inc ($10.67 million of which 100% was Pharmaceutical).

Sales Analysis. Sales increased substantially in 2018: Ascendis Pharma A/S reported sales of $12.47 million for the year ending December of 2018. This represents an increase of 615.3% versus 2017, when the company's sales were $1.74 million.
  Stock Performance Chart for Ascendis Pharma A/S - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 107.56
(Figures in U.S. Dollars)
1 Week -6.6%   13 Weeks -5.2%  
4 Weeks -3.7%   52 Weeks 66.2%  
Ascendis Pharma A/S - ADR Key Data:
  Ticker: ASND Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 12,467,170
(Year Ending Jan 2019).
Employees: 216
  Currency: U.S. Dollars Market Cap: 5,134,876,431
  Fiscal Yr Ends: December Shares Outstanding: 47,739,647
  Share Type: Common Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.